Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Country scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.7 List of Secondary Sources
1.8 Objectives
Chapter 2 Executive Summary
2.1 Europe Veterinary Pharmaceuticals Market Summary
Chapter 3 Europe Veterinary Pharmaceuticals Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping, 2020
3.3 Europe Veterinary Pharmaceuticals Market Dynamics
3.3.1 Market driver analysis
3.3.2 Market restraint analysis
3.3.3. Market opportunity analysis
3.3.4. Market challenge analysis
3.4 Europe Veterinary Pharmaceuticals Market Analysis Tools: Porters
3.4.1 Supplier Power
3.4.2. Buyer Power
3.4.3. Substitution Threat
3.4.4. Threat of New Entrants
3.4.5. Competitive Rivalry
3.5 Europe Veterinary Pharmaceuticals Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
3.5.1 Political/Legal Landscape
3.5.2 Economic Landscape
3.5.3 Social Landscape
3.5.4 Technology Landscape
3.6. Value Chain Analysis
3.7. Cost Structure Analysis
3.8. SWOT Analysis
3.9. User Perspective Analysis
3.9.1. Consumer Behavior Analysis
3.9.2. Pet Animal Owner Profiles
3.9.3. Market Influencer Analysis
3.10. Regulatory Landscape
3.11. Patent-Off-Dates Analysis for Major Veterinary Pharmaceuticals
3.12. Product Pipeline Analysis
Chapter 4 COVID-19 Impact Analysis
4.1 COVID-19 Disease Prevalence Analysis
4.2. Regulatory requirements/changes due to COVID-19
4.3. Strategies implemented by companies
Chapter 5 Europe Veterinary Pharmaceuticals Market: Segment Analysis, By Animal Type, 2016 - 2028 (USD Million)
5.1 Animal Type Market Share Analysis, 2020 & 2028
5.2 Europe Veterinary Pharmaceuticals market, by Animal Type, 2016 to 2028
5.3 Companion Animals
5.3.1 Companion Animals market, 2016 - 2028 (USD Million)
5.3.2. Dogs
5.3.2.1 Dogs market, 2016 - 2028 (USD Million)
5.3.3 Cats
5.3.3.1 Cats market, 2016 - 2028 (USD Million)
5.3.4 Horses
5.3.4.1 Horses market, 2016 - 2028 (USD Million)
5.3.5 Others (Small mammals, Birds)
5.3.5.1 Others (Small mammals, Birds) market, 2016 - 2028 (USD Million)
5.4 Livestock Animals
5.4.1 Livestock Animals market, 2016 - 2028 (USD Million)
5.4.2 Pigs
5.4.2.1 Pigs market, 2016 - 2028 (USD Million)
5.4.3 Cattle
5.4.3.1 Cattle market, 2016 - 2028 (USD Million)
5.4.4 Sheep & Goats
5.4.4.1 Sheep & Goats market, 2016 - 2028 (USD Million)
5.4.5 Others
5.4.5.1 Others market, 2016 - 2028 (USD Million)
Chapter 6 Europe Veterinary Pharmaceuticals Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
6.1 Product Market Share Analysis, 2020 & 2028
6.2 Europe Veterinary Pharmaceuticals market, by Product, 2016 to 2028
6.3 Parasiticides
6.3.1 Parasiticides market, 2016 - 2028 (USD Million)
6.4 Anti-infectives
6.4.1 Anti-infectives market, 2016 - 2028 (USD Million)
6.5 Anti-inflammatory
6.5.1 Anti-inflammatory market, 2016 - 2028 (USD Million)
6.6 Analgesics
6.6.1 Analgesics market, 2016 - 2028 (USD Million)
6.7 Others
6.7.1 Others market, 2016 - 2028 (USD Million)
Chapter 7 Europe Veterinary Pharmaceuticals Market: Segment Analysis, By Mode of Administration, 2016 - 2028 (USD Million)
7.1 Mode of Administration Market Share Analysis, 2020 & 2028
7.2 Europe Veterinary Pharmaceuticals Market, by Mode of Administration, 2016 to 2028
7.3 Oral
7.3.1 Oral market, 2016 - 2028 (USD Million)
7.4 Parenteral
7.4.1 Parenteral market, 2016 - 2028 (USD million)
z 7.5 Topical
7.5.1 Topical market, 2016 - 2028 (USD million)
7.6 Others
7.6.1 Others market, 2016 - 2028 (USD million)
Chapter 8 Europe Veterinary Pharmaceuticals Market: Segment Analysis, By Distribution Channel, 2016 - 2028 (USD Million)
8.1 Distribution Channel Market Share Analysis, 2020 & 2028
8.2 Europe Veterinary Pharmaceuticals Market, by Distribution Channel, 2016 to 2028
8.3 Pharmacies & retail stores
8.3.1 Pharmacies & retail stores market, 2016 - 2028 (USD Million)
8.4 Digital or e-commerce stores
8.4.1 Digital or e-commerce stores market, 2016 - 2028 (USD million)
8.5 Veterinary Hospitals & Clinics
8.5.1 Veterinary Hospitals & Clinics market, 2016 - 2028 (USD Million)
Chapter 9 Europe Veterinary Pharmaceuticals Market: Country Market Analysis 2016 - 2028 (USD Million)
9.1 Country Movement Analysis, 2020 & 2028
9.2 Country Market Snapshot
9.3 Europe
9.3.1 Europe Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.2 U.K.
9.3.2.1 U.K. Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.3 Germany
9.3.3.1 Germany Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.5.4 France
9.3.4.1 France Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.5 Italy
9.3.5.1 Italy Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.6 Spain
9.3.6.1 Spain Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.7 Netherlands
9.3.7.1 Netherlands Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.8 Poland
9.3.8.1 Poland Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.9 Hungary
9.3.9.1 Hungary Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.10 Denmark
9.3.10.1 Denmark Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.11 Sweden
9.3.11.1 Sweden Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
9.3.12 Portugal
9.3.12.1 Portugal Veterinary Pharmaceuticals Market, 2016 - 2028 (USD Million)
Chapter 10 Europe Veterinary Pharmaceuticals Market - Competitive Analysis
10.1 Market Participant Categorization
10.1.1. Company Market Share Analysis
10.1.2. Synergy Analysis: Major Deals & Strategic Alliances
10.1.3. Market Leaders
10.1.4. Innovators
10.2. List of Key Companies
10.3. List of Blockbuster Drugs
10.4. Detailed list of Major Veterinary Pharmaceuticals, by Country
Chapter 11 Europe Veterinary Pharmaceuticals Market - Company Profiles
11.1 MSD
11.1.1 Company overview
11.1.2 Financial Performance
11.1.3 Product benchmarking
11.1.4 Strategic initiatives
11.2 Ceva
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.2.4 Strategic initiatives
11.3 Vetoquinol S.A.
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Zoetis
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 Boehringer Ingelheim International GmbH
11.5.1 Company overview
11.5.2 Financial performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 Elanco
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.6.4 Strategic initiatives
11.7 Virbac
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.7.4 Strategic initiatives
11.8 Calier
11.8.1 Company overview
11.8.2 Financial performance
11.8.3 Product benchmarking
11.8.4 Strategic initiatives
11.9 Bimeda, Inc.
11.9.1 Company overview
11.9.2 Financial performance
11.9.3 Product benchmarking
11.9.4 Strategic initiatives
11.10 Prodivet pharmaceuticals sa/nv
11.10.1 Company overview
11.10.2 Financial performance
11.10.3 Product benchmarking
11.10.4 Strategic initiatives



List of Figures

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity workflow analysis
Fig. 9 Parent market outlook
Fig. 10 Ancillary market outlook
Fig. 11 Europe veterinary pharmaceuticals market snapshot, 2020 (USD Million)
Fig. 12 Value chain analysis
Fig. 13 Drug development process for veterinary pharmaceuticals
Fig. 14 Consumer behavior analysis
Fig. 15 Pet population in Europe, 2020
Fig. 16 Factors influencing veterinary pharmaceuticals market (%)
Fig. 17 Factors influencing U.K. market (%)
Fig. 18 Factors influencing Germany market (%)
Fig. 19 Factors influencing France market (%)
Fig. 20 Factors influencing Italy market (%)
Fig. 21 Factors influencing Spain market (%)
Fig. 22 Factors influencing Poland market (%)
Fig. 23 Factors influencing Netherlands market (%)
Fig. 24 Factors influencing Hungary market (%)
Fig. 25 Factors influencing Denmark market (%)
Fig. 26 Factors influencing Sweden market (%)
Fig. 27 Factors influencing Portugal market (%)
Fig. 28 Company Market Share Analysis, 2020
Fig. 29 COVID-19 cumulative confirmed cases: August 2020 to August 2021, EU5
Fig. 30 Europe Veterinary pharmaceuticals market: Product share analysis, 2020 & 2028
Fig. 31 Europe Veterinary pharmaceuticals Product dashboard
Fig. 32 Europe veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 33 Europe parasiticides market, 2016 - 2028 (USD Million)
Fig. 34 Europe anti-infectives market, 2016 - 2028 (USD Million)
Fig. 35 Europe anti-inflammatory market, 2016 - 2028 (USD Million)
Fig. 36 Europe analgesics market, 2016 - 2028 (USD Million)
Fig. 37 Europe others market, 2016 - 2028 (USD Million)
Fig. 38 Europe veterinary pharmaceuticals Country outlook, 2020 & 2028
Fig. 39 U.K. Veterinary pharmaceuticals market by countries, 2016 - 2028 (USD Million)
Fig. 40 Germany pharmaceuticals medicine market, 2016 - 2028 (USD Million)
Fig. 41 France pharmaceuticals medicine market, 2016 - 2028 (USD Million)
Fig. 42 Italy veterinary pharmaceuticals market by countries, 2016 - 2028 (USD Million)
Fig. 43 Spain veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 44 Sweden veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 45 Denmark veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 46 Netherlands pharmaceuticals medicine market, 2016 - 2028 (USD Million)
Fig. 47 Poland veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 48 Portugal veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 49 Hungary veterinary pharmaceuticals market, 2016 - 2028 (USD Million)
Fig. 50 Penetration & growth prospect mapping, 2020
Fig. 51 Europe veterinary pharmaceuticals market dynamics analysis
Fig. 52 Europe veterinary pharmaceuticals market driver analysis
Fig. 53 Europe veterinary pharmaceuticals market restraint analysis
Fig. 54 Market participant categorization
Fig. 55 Europe Veterinary pharmaceuticals market: Animal type share analysis, 2020 & 2028
Fig. 56 Europe Veterinary pharmaceuticals Animal type dashboard
Fig. 57 Companion Animals market, 2016 - 2028 (USD Million)
Fig. 58 Dogs market, 2016 - 2028 (USD Million)
Fig. 59 Cats market, 2016 - 2028 (USD Million)
Fig. 60 Horses market, 2016 - 2028 (USD Million)
Fig. 61 Others (Small mammals, Birds) market, 2016 - 2028 (USD Million)
Fig. 62 Livestock Animals market, 2016 - 2028 (USD Million)
Fig. 63 Pigs market, 2016 - 2028 (USD Million)
Fig. 64 Cattle market, 2016 - 2028 (USD Million)
Fig. 65 Sheep & Goats market, 2016 - 2028 (USD Million)
Fig. 66 Others (Poultry, Aquatics) market, 2016 - 2028 (USD Million)
Fig. 67 Europe Veterinary pharmaceuticals market: Mode of Administration share analysis, 2020 & 2028
Fig. 68 Europe Veterinary pharmaceuticals: Mode of Administration dashboard
Fig. 69 Oral market, 2016 - 2028 (USD Million)
Fig. 70 Parenteral market, 2016 - 2028 (USD Million)
Fig. 71 Topical market, 2016 - 2028 (USD Million)
Fig. 72 Others (Inhalation, Carrier) market, 2016 - 2028 (USD Million)
Fig. 73 Europe Veterinary pharmaceuticals market: Distribution Channel share analysis, 2020 & 2028
Fig. 74 Europe Veterinary pharmaceuticals: Distribution Channel dashboard
Fig. 75 Veterinary Hospitals & clinics market, 2016 - 2028 (USD Million)
Fig. 76 Pharmacies & retail stores market, 2016 - 2028 (USD Million)
Fig. 77 Digital or e-commerce stores market, 2016 - 2028 (USD Million)

List of Tables

List of Tables

Table 1 List of secondary sources
Table 2 List of Key companies
Table 3 Europe Veterinary Pharmaceuticals market, by country, 2016 - 2028 (USD Million)
Table 4 Europe Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 5 Europe Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 6 Europe Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 7 Europe Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 8 U.K. Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 9 U.K. Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 10 U.K. Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 11 U.K. Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 12 Germany Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 13 Germany Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 14 Germany Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 15 Germany Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 16 France Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 17 France Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 18 France Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 19 France Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 20 Italy Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 21 Italy Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 22 Italy Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 23 Italy Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 24 Spain Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 25 Spain Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 26 Spain Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 27 Spain Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 28 Netherlands Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 29 Netherlands Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 30 Netherlands Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 31 Netherlands Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 32 Poland Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 33 Poland Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 34 Poland Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 35 Poland Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 36 Hungary Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 37 Hungary Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 38 Hungary Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 39 Hungary Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 40 Denmark Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 41 Denmark Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 42 Denmark Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 43 Denmark Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 44 Sweden Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 45 Sweden Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 46 Sweden Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 47 Sweden Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 48 Portugal Veterinary Pharmaceuticals market, by animal type, 2016 - 2028 (USD Million)
Table 49 Portugal Veterinary Pharmaceuticals market, by product, 2016 - 2028 (USD Million)
Table 50 Portugal Veterinary Pharmaceuticals market, by mode of administration, 2016 - 2028 (USD Million)
Table 51 Portugal Veterinary Pharmaceuticals market, by distribution channel, 2016 - 2028 (USD Million)
Table 52 List of national competent authorities in the EEA for veterinary medicines
Table 53 Elanco Patent-Off-Dates Analysis for Key Veterinary Pharmaceuticals
Table 54 Zoetis Patent-Off-Dates Analysis for Key Veterinary Pharmaceuticals
Table 55 Product Pipeline Analysis
Table 56 Gross value of key patents, licenses, and Marketing authorizations (Virbac)
Table 57 Dechra Pharmaceuticals Product Pipeline Analysis
Table 57 Kindred Biosciences, Inc. Product Pipeline Snapshot
Table 59 List of Mergers & Acquisitions
Table 60 List of blockbuster drugs, by major companies
Table 61 Detailed list of major veterinary pharmaceuticals, by country